We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZPN
976
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $3.89M | 0.01% |
101,136
+14,785
| +17% | +$569K |
|
977
Nu Skin
NUS
$251M
| $3.89M | 0.01% |
64,639
-8,620
| -12% | -$439K |
|
|
LXK
978
DELISTED
Lexmark Intl Inc
LXK
| $3.89M | 0.01% |
91,933
+4,800
| +6% | +$197K |
|
979
Haemonetics
HAE
$3.88B
| $3.89M | 0.01% |
86,600
+865
| +1% | +$36.2K |
|
|
THOR
980
DELISTED
THORATEC CORPORATION
THOR
| $3.89M | 0.01% |
92,780
+10,046
| +12% | +$383K |
|
981
Cabot Corp
CBT
$4.23B
| $3.88M | 0.01% |
86,275
+4,984
| +6% | +$220K |
|
982
Transocean
RIG
$5.78B
| $3.87M | 0.01% |
263,664
-740
| -0.3% | -$12K |
|
|
UFS
983
DELISTED
DOMTAR CORPORATION (New)
UFS
| $3.86M | 0.01% |
83,570
+5,985
| +8% | +$252K |
|
|
VRNT
984
DELISTED
Verint Systems
VRNT
| $3.86M | 0.01% |
122,265
+18,246
| +18% | +$537K |
|
985
Wintrust Financial
WTFC
$11B
| $3.86M | 0.01% |
80,887
+1,025
| +1% | +$47.4K |
|
986
Acadia Realty Trust
AKR
$2.97B
| $3.85M | 0.01% |
110,341
+5,850
| +6% | +$204K |
|
987
Deckers Outdoor
DECK
$13.6B
| $3.85M | 0.01% |
316,686
+20,340
| +7% | +$261K |
|
988
Associated Banc-Corp
ASB
$5.99B
| $3.84M | 0.01% |
206,504
+10,764
| +5% | +$195K |
|
989
Silicon Laboratories
SLAB
$7.19B
| $3.83M | 0.01% |
75,530
+6,418
| +9% | +$312K |
|
990
Marriott Vacations Worldwide
VAC
$3.35B
| $3.83M | 0.01% |
47,238
+785
| +2% | +$60.7K |
|
|
BRCD
991
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $3.83M | 0.01% |
322,506
+17,350
| +6% | +$207K |
|
|
ALE
992
DELISTED
Allete
ALE
| $3.82M | 0.01% |
72,416
+1,015
| +1% | +$55.8K |
|
|
PPLI
993
People Inc
PPLI
$3.45B
| $3.81M | 0.01% |
315,631
+10,463
| +3% | +$121K |
|
994
Novartis
NVS
$291B
| $3.79M | 0.01% |
42,924
-1,950
| -4% | -$173K |
|
995
Zillow
ZG
$8.19B
| $3.77M | 0.01% |
112,809
+39,750
| +54% | +$1.4M |
|
996
Trustmark
TRMK
$2.8B
| $3.77M | 0.01% |
155,265
+353
| +0.2% | +$8.19K |
|
997
Enovis
ENOV
$1.78B
| $3.77M | 0.01% |
45,826
+1,517
| +3% | +$127K |
|
998
First Industrial Realty Trust
FR
$8.5B
| $3.76M | 0.01% |
175,493
+1,085
| +0.6% | +$23.3K |
|
999
Helen of Troy
HELE
$658M
| $3.75M | 0.01% |
46,054
+2,290
| +5% | +$175K |
|
|
ATHN
1000
DELISTED
Athenahealth, Inc.
ATHN
| $3.75M | 0.01% |
31,419
+947
| +3% | +$126K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.